About
Liquid Biopsy
Areas of Focus
Categories
DiagnosticsBiotech
Team (13)
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
3
As Collaborator
1
Total Enrollment
31,526
By Phase
NA: 3
By Status
UNKNOWN: 2RECRUITING: 1TERMINATED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT06803771Collaborator
Surveillance of Pancreatic Health After Diabetes Diagnosis
NARecruiting
15,000 participants
Started: May 21, 2025 · Completed: Feb 28, 2029
NCT05188586Lead Sponsor
New Onset Diabetes Management for Earlier Detection of Pancreatic Cancer (NODMED)
NATerminated
26 participants
Started: Oct 31, 2022 · Completed: Mar 16, 2023
NCT05188573Lead Sponsor
EpiDetect Study: Clinical Validation of a Pancreatic Cancer Detection Test in New-Onset Diabetes Patients
NAUnknown
10,000 participants
Started: Jun 1, 2022 · Completed: May 31, 2025
NCT03869814Lead Sponsor
Non-invasive Liquid Biopsy Analysis of Epigenomics Signatures in Multiple Cancer Types
N/AUnknown
6,500 participants
Started: Apr 5, 2018 · Completed: Sep 13, 2023
Locations (1)
Headquarters
San Mateo, CA, United States
Map
Loading map...